Journal of Nursing

Application and Nursing of Non - Hodgkin 's Lymphoma in the Treatment of CD20+ by Rituximab Rapid Infusion Method

Zhang Zhang, Xiaomin Wang, Xiujuan Zeng


The use of Rituxan (rituximab) rapid infusion method (90 min infusion method) in the treatment of CD20+ Non-Hodgkin's Lymphoma (NHL) in the treatment of safety and infusion of adverse care. In the case of 139 patients with CD20+ Non-Hodgkin's Lymphoma who were treated with rituximab for the first time, patients who did not experience grade III ~ IV infusion were treated with rapid infusion in their follow-up rituximab and put forward nursing measures.


rituximab; rapid infusion; Non-Hodgkin's Lymphoma; infusion reaction; nursing

Full Text:



Wang Zhi Jun, Wu Yue Bing. Rituximab Treatment of Diffuse Large B-cell Lymphoma Clinical Observation [J]. Cancer Prevention and Treatment Research, 2011, 38 (08): 947-949.

Li Jian (review). Rituximab Treatment of Acute Lymphoblastic Leukemia [J]. International Journal of Blood Transfusion and Hematology, 2011, 34 (4): 308-311.

Sehn LH, Donaldson J, Filewich A, et al. Rapid Infusion Rituximab in Combination with Corticosteroid-containing Chemotherapy or as Maintenance Therapy is Well Tolerated and Can Safely be Delivered in the Community Setting [J]. Blood, 2007,109 (10): 4171-4173.



  • There are currently no refbacks.

Copyright (c) 2017 Zhang Zhang

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.